Literature DB >> 25107308

Two C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate demethylation and impact environmental stress adaptation in Aspergillus fumigatus.

Sara J Blosser1, Brittney Merriman1, Nora Grahl1, Dawoon Chung1, Robert A Cramer1.   

Abstract

The human pathogen Aspergillus fumigatus adapts to stress encountered in the mammalian host as part of its ability to cause disease. The transcription factor SrbA plays a significant role in this process by regulating genes involved in hypoxia and low-iron adaptation, antifungal drug responses and virulence. SrbA is a direct transcriptional regulator of genes encoding key enzymes in the ergosterol biosynthesis pathway, including erg25A and erg25B, and ΔsrbA accumulates C4-methyl sterols, suggesting a loss of Erg25 activity [C4-sterol methyl oxidase (SMO)]. Characterization of the two genes encoding SMOs in Aspergillus fumigatus revealed that both serve as functional C4-demethylases, with Erg25A serving in a primary role, as Δerg25A accumulates more C4-methyl sterol intermediates than Δerg25B. Single deletion of these SMOs revealed alterations in canonical ergosterol biosynthesis, indicating that ergosterol may be produced in an alternative fashion in the absence of SMO activity. A Δerg25A strain displayed moderate susceptibility to hypoxia and the endoplasmic reticulum stress-inducing agent DTT, but was not required for virulence in murine or insect models of invasive aspergillosis. Inducing expression of erg25A partially restored the hypoxia growth defect of ΔsrbA. These findings implicated Aspergillus fumigatus SMOs in the maintenance of canonical ergosterol biosynthesis and indicated an overall involvement in the fungal stress response.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25107308      PMCID: PMC4219106          DOI: 10.1099/mic.0.080440-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  74 in total

1.  Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol.

Authors:  G F Bammert; J M Fostel
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  Dissecting the sterol C-4 demethylation process in higher plants. From structures and genes to catalytic mechanism.

Authors:  Alain Rahier
Journal:  Steroids       Date:  2010-12-13       Impact factor: 2.668

Review 3.  Biogenesis, molecular regulation and function of plant isoprenoids.

Authors:  Florence Bouvier; Alain Rahier; Bilal Camara
Journal:  Prog Lipid Res       Date:  2005-10-21       Impact factor: 16.195

4.  An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.

Authors:  B A Janowski; P J Willy; T R Devi; J R Falck; D J Mangelsdorf
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  The ERG28-encoded protein, Erg28p, interacts with both the sterol C-4 demethylation enzyme complex as well as the late biosynthetic protein, the C-24 sterol methyltransferase (Erg6p).

Authors:  Caiqing Mo; Martin Valachovic; Martin Bard
Journal:  Biochim Biophys Acta       Date:  2004-11-08

6.  Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans.

Authors:  Yun C Chang; Clara M Bien; Hyeseung Lee; Peter J Espenshade; Kyung J Kwon-Chung
Journal:  Mol Microbiol       Date:  2007-05       Impact factor: 3.501

Review 7.  The damage-response framework of microbial pathogenesis and infectious diseases.

Authors:  Liise-anne Pirofski; Arturo Casadevall
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.

Authors:  S L Kelly; D C Lamb; A J Corran; B C Baldwin; D E Kelly
Journal:  Biochem Biophys Res Commun       Date:  1995-02-27       Impact factor: 3.575

9.  Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans.

Authors:  Saif Hameed; Sanjiveeni Dhamgaye; Ashutosh Singh; Shyamal K Goswami; Rajendra Prasad
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

10.  Transcriptomic and proteomic analyses of the Aspergillus fumigatus hypoxia response using an oxygen-controlled fermenter.

Authors:  Bridget M Barker; Kristin Kroll; Martin Vödisch; Aurélien Mazurie; Olaf Kniemeyer; Robert A Cramer
Journal:  BMC Genomics       Date:  2012-02-06       Impact factor: 3.969

View more
  15 in total

1.  Med15B Regulates Acid Stress Response and Tolerance in Candida glabrata by Altering Membrane Lipid Composition.

Authors:  Yanli Qi; Hui Liu; Jiayin Yu; Xiulai Chen; Liming Liu
Journal:  Appl Environ Microbiol       Date:  2017-08-31       Impact factor: 4.792

2.  Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.

Authors:  Nanbiao Long; Xiaoling Xu; Qiuqiong Zeng; Hong Sang; Ling Lu
Journal:  Appl Environ Microbiol       Date:  2017-02-01       Impact factor: 4.792

3.  Long Terminal Repeat Retrotransposon Afut4 Promotes Azole Resistance of Aspergillus fumigatus by Enhancing the Expression of sac1 Gene.

Authors:  Mandong Hu; Zongwei Li; Dingchen Li; Jingya Zhao; Yong Chen; Zelei Wang; Fangyan Chen; Li Han
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

4.  Identification and Characterization of a Novel Aspergillus fumigatus Rhomboid Family Putative Protease, RbdA, Involved in Hypoxia Sensing and Virulence.

Authors:  Yakir Vaknin; Falk Hillmann; Rossana Iannitti; Netali Ben Baruch; Hana Sandovsky-Losica; Yona Shadkchan; Luigina Romani; Axel Brakhage; Olaf Kniemeyer; Nir Osherov
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

5.  ChIP-seq and in vivo transcriptome analyses of the Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia response and virulence.

Authors:  Dawoon Chung; Bridget M Barker; Charles C Carey; Brittney Merriman; Ernst R Werner; Beatrix E Lechner; Sourabh Dhingra; Chao Cheng; Wenjie Xu; Sara J Blosser; Kengo Morohashi; Aurélien Mazurie; Thomas K Mitchell; Hubertus Haas; Aaron P Mitchell; Robert A Cramer
Journal:  PLoS Pathog       Date:  2014-11-06       Impact factor: 6.823

6.  An LaeA- and BrlA-Dependent Cellular Network Governs Tissue-Specific Secondary Metabolism in the Human Pathogen Aspergillus fumigatus.

Authors:  Abigail L Lind; Fang Yun Lim; Alexandra A Soukup; Nancy P Keller; Antonis Rokas
Journal:  mSphere       Date:  2018-03-14       Impact factor: 4.389

Review 7.  Regulation of Sterol Biosynthesis in the Human Fungal Pathogen Aspergillus fumigatus: Opportunities for Therapeutic Development.

Authors:  Sourabh Dhingra; Robert A Cramer
Journal:  Front Microbiol       Date:  2017-02-01       Impact factor: 5.640

8.  Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.

Authors:  Mark S Gresnigt; Abdessalem Rekiki; Orhan Rasid; Amélie Savers; Grégory Jouvion; Eric Dannaoui; Marianna Parlato; Catherine Fitting; Matthias Brock; Jean-Marc Cavaillon; Frank L van de Veerdonk; Oumaïma Ibrahim-Granet
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

9.  Characterization of the Paracoccidioides Hypoxia Response Reveals New Insights into Pathogenesis Mechanisms of This Important Human Pathogenic Fungus.

Authors:  Patrícia de Sousa Lima; Dawoon Chung; Alexandre Melo Bailão; Robert A Cramer; Célia Maria de Almeida Soares
Journal:  PLoS Negl Trop Dis       Date:  2015-12-10

10.  Transcriptional Heterogeneity of Cryptococcus gattii VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways.

Authors:  Rhys A Farrer; Christopher B Ford; Johanna Rhodes; Toni Delorey; Robin C May; Matthew C Fisher; Elaine Cloutman-Green; Francois Balloux; Christina A Cuomo
Journal:  mSphere       Date:  2018-10-24       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.